<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8607709</article-id>
    <article-id pub-id-type="publisher-id">4470</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-021-04470-4</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>trioPhaser: using Mendelian inheritance logic to improve genomic phasing of trios</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Miller</surname>
          <given-names>Dustin B.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2001-5640</contrib-id>
        <name>
          <surname>Piccolo</surname>
          <given-names>Stephen R.</given-names>
        </name>
        <address>
          <email>stephen_piccolo@byu.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.253294.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9115</institution-id><institution>Department of Biology, </institution><institution>Brigham Young University, </institution></institution-wrap>Provo, UT 84602 USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>22</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>22</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>22</volume>
    <elocation-id>559</elocation-id>
    <history>
      <date date-type="received">
        <day>18</day>
        <month>6</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>8</day>
        <month>11</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">When analyzing DNA sequence data of an individual, knowing which nucleotide was inherited from each parent can be beneficial when trying to identify certain types of DNA variants. Mendelian inheritance logic can be used to accurately phase (haplotype) the majority (67–83%) of an individual's heterozygous nucleotide positions when genotypes are available for both parents (trio). However, when all members of a trio are heterozygous at a position, Mendelian inheritance logic cannot be used to phase. For such positions, a computational phasing algorithm can be used. Existing phasing algorithms use a haplotype reference panel, sequencing reads, and/or parental genotypes to phase an individual; however, they are limited in that they can only phase certain types of variants, require a specific genotype build, require large amounts of storage capacity, and/or require long run times. We created trioPhaser to address these challenges.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">trioPhaser uses gVCF files from an individual and their parents as initial input, and then outputs a phased VCF file. Input trio data are first phased using Mendelian inheritance logic. Then, the positions that cannot be phased using inheritance information alone are phased by the <italic>SHAPEIT4</italic> phasing algorithm. Using whole-genome sequencing data of 52 trios, we show that trioPhaser, on average, increases the total number of phased positions by 21.0% and 10.5%, respectively, when compared to the number of positions that <italic>SHAPEIT4</italic> or Mendelian inheritance logic can phase when either is used alone. In addition, we show that the accuracy of the phased calls output by trioPhaser are similar to linked-read and read-backed phasing.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p id="Par3">trioPhaser is a containerized software tool that uses both Mendelian inheritance logic and <italic>SHAPEIT4</italic> to phase trios when gVCF files are available. By implementing both phasing methods, more variant positions are phased compared to what either method is able to phase alone.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Haplotyping</kwd>
      <kwd>Phasing</kwd>
      <kwd>Trios</kwd>
      <kwd>Genomics</kwd>
      <kwd>Next-generation sequencing</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par7">When analyzing whole-genome sequence (WGS) data of an individual, the parent of origin for each nucleotide is often unknown [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Investigators can identify homozygous-alternate and simple-heterozygous variants, but more complex variants, such as compound-heterozygous variants, are unidentifiable unless the genotype data are phased [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Phasing (haplotyping) is a process that helps differentiate between maternally and paternally derived nucleotides [<xref ref-type="bibr" rid="CR1">1</xref>]. Phase can be estimated with computational methods that rely on haplotype evidence from multiple sources; different software programs may support one or more of the following sources: haplotype reference panel, sequence reads, and/or familial genotypes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. It has been shown that using trio data (data from each parent and the child) as part of the phasing process can improve the number of accurately phased genotypes [<xref ref-type="bibr" rid="CR1">1</xref>]. In fact, approximately 67–83% of an individuals’ heterozygous sites can be phased using Mendelian inheritance logic [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
    <p id="Par8">Some computational phasing programs, such as <italic>WhatsHap</italic> [<xref ref-type="bibr" rid="CR6">6</xref>] and <italic>SHAPEIT2</italic> [<xref ref-type="bibr" rid="CR9">9</xref>] can take parental genotypes into consideration when making haplotype calls for the child. However, these programs have limitations. For example, <italic>WhatsHap</italic> requires BAM and VCF files as input [<xref ref-type="bibr" rid="CR6">6</xref>]. BAM files from WGS data can be over 100 gigabytes in size, thereby requiring much computational storage when many samples are being analyzed [<xref ref-type="bibr" rid="CR10">10</xref>]. In addition, <italic>WhatsHap</italic> only outputs phased heterozygous positions, which requires the user to add homozygous alternate positions back into the phased file. <italic>SHAPEIT2</italic> can use a single input type or a combination of input types to estimate phase. Input types supported by <italic>SHAPEIT2</italic> include VCF files, BAM files, a haplotype reference panel, and parental genotypes [<xref ref-type="bibr" rid="CR9">9</xref>]. However, <italic>SHAPEIT2</italic> does not provide a haplotype reference panel that supports genome build GRCh38. Therefore, VCF files that were generated using GRCh38 require conversion to a previous build through a process that may cause hundreds of thousands of variants to be removed, thereby reducing the total number of variants that are available to be phased [<xref ref-type="bibr" rid="CR11">11</xref>]. A newer phasing method, <italic>SHAPEIT4</italic>, does not take parental genotype data as direct input into the phasing program, but it does allow pre-phased data to be used as input to increase the accuracy of haplotype calls, and it does support data aligned with GRCh38 [<xref ref-type="bibr" rid="CR5">5</xref>]. However, <italic>SHAPEIT4</italic> does not provide a means to pre-phase the data, nor does it retain all of the pre-phased data in the final output for variant positions that are not listed in the haplotype reference panel file or that are multi-allelic. Thus, we created trioPhaser, a single-step, containerized application that accepts gVCF files from trio(s) as input, pre-phases the data using Mendelian inheritance logic, and then uses the pre-phased data as input into <italic>SHAPEIT4</italic>, producing a phased VCF file (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>trioPhaser workflow diagram. All steps are conducted within a Docker container. Input files are shown in red and the output file is shown in blue. Steps 1–5 produce temporary output files which are used as input to the subsequent step</p></caption><graphic xlink:href="12859_2021_4470_Fig1_HTML" id="MO1"/></fig></p>
    <p id="Par9">Our method overcomes some of the limitations that current phasing software presents, without creating a completely new phasing algorithm. We are able to use the information that gVCF files provide to pre-phase the data of the child using Mendelian inheritance as a guide. gVCF files are different from VCF files in that both variant and invariant positions are included as part of the file. This proves beneficial as parental genotype information can be compared to a child’s, position for position, in an effort to determine which parent each nucleotide was inherited from. This pre-phase step allows <italic>SHAPEIT4</italic> to use a priori information as part of the phasing process and outputs the data in a conventional format with the paternal allele first, followed by the maternal allele. The phased output file generated by <italic>SHAPEIT4</italic> excludes a priori positions that are not contained in the haplotype reference panel or that are multi-allelic. Therefore, after <italic>SHAPEIT4</italic> phases the data, trioPhaser adds any Mendelian-phased positions to the final output that were excluded.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <sec id="Sec3">
      <title>Software</title>
      <p id="Par10">trioPhaser consists of a single Python (<ext-link ext-link-type="uri" xlink:href="https://python.org">https://python.org</ext-link>) script (“trio_phaser.py”) that executes within a Docker container [<xref ref-type="bibr" rid="CR12">12</xref>]. This script provides logic for processing data files and invoking third-party tools including <italic>GATK</italic> [<xref ref-type="bibr" rid="CR13">13</xref>] (version 4.0.5.1), <italic>bcftools</italic> [<xref ref-type="bibr" rid="CR14">14</xref>] (version 1.9), and <italic>SHAPEIT4</italic> [<xref ref-type="bibr" rid="CR5">5</xref>] (version 4.1.3). These tools are available within the container. Therefore, in order to execute trioPhaser, the user needs only to install the Docker engine and download the Docker image. When multiple cores are available, <italic>SHAPEIT4</italic> will phase multiple autosomal chromosomes simultaneously, thereby decreasing run-time.</p>
    </sec>
    <sec id="Sec4">
      <title>Inputs</title>
      <p id="Par11">When a single trio is being phased, trioPhaser has 5 required arguments: (1) gVCF file of the child, (2) gVCF file of the father, (3) gVCF file of the mother, (4) name of the phased output file, and (5) path where haplotype reference files will be saved. Alternatively, when multiple trios need to be phased, trioPhaser has 2 required arguments: (1) a TSV file that contains one trio per line where the first, second, and third columns are file paths to the child, father, and mother gVCF file, respectively, and the fourth column is the path to the output file, and (2) path where haplotype reference files will be saved. There are also 3 optional arguments regardless of whether a single trio or multiple trios are phased: (1) the number of CPU cores to use for processing (default = 2), (2) which genome build the input files were created with (default = GRCh38, GRCh37 is also supported), and (3) the minimum Phred-scaled quality score a variant position is able to have (default = 30).</p>
    </sec>
    <sec id="Sec5">
      <title>Pipeline design</title>
      <p id="Par12">Although trioPhaser executes with a single Python script, there are six steps performed by the script in order to produce a phased VCF file (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). For <italic>step 1</italic>, the child’s gVCF file is used to produce a temporary file that contains all variant positions. In addition, the gVCF files for each parent are used to produce temporary VCF files that contain positions that are congruent with the child’s retained variant positions. These positions may be variant or invariant as long as they are found within the newly created file. The purpose of this step is to retain pertinent information and decrease the size of the files. Decreasing file sizes decreases the run-time of subsequent steps.</p>
      <p id="Par13"><italic>Step 2</italic> uses <italic>GATK</italic>’s “CombineGVCFs” tool to combine the temporary VCF files from Step 1 into a single file. Then, <italic>step 3</italic> uses <italic>GATK</italic>’s “GenotypeGVCFs” tool to joint-genotype the calls. Joint-genotyping can help determine if a poorly called variant is a “true” variant by comparing it to the other samples.</p>
      <p id="Par14">Once genotyped, <italic>step 4</italic> separates the file into 22 VCF files and creates a pre-phased file, or scaffold, for each autosome. To create the scaffold files, Mendelian inheritance logic is used. For positions of the child that can be used to determine which variant came from which parent, the haplotypes of these positions are written to a temporary scaffold file. For example, if the mother is homozygotic for the reference allele (A/A), the father is heterozygotic (A/G), and the child is heterozygotic (A/G), then it can be determined that the reference allele (A) was inherited from the mother and the variant allele (G) was inherited from the father. However, when both parents and the child are heterozygotic (A/G), Mendelian inheritance alone cannot be used to determine which nucleotide came from which parent. <italic>SHAPEIT4</italic> uses surrounding pre-phased positions and information from the 1000 Genomes Project [<xref ref-type="bibr" rid="CR15">15</xref>] haplotype reference panel to phase in such scenarios.</p>
      <p id="Par15"><italic>Step 5</italic> uses the autosome VCF files, the scaffold VCF files, and the haplotype reference panel as input into <italic>SHAPEIT4</italic> to phase each autosome under default parameters. Only positions that are in the haplotype reference panel and that are bi-allelic are included in the phased VCF files output by <italic>SHAPEIT4</italic>. Therefore, <italic>step 6</italic> uses the scaffold files and the <italic>SHAPEIT4</italic>-phased chromosome files to create a single VCF file that includes all Mendelian-phased and <italic>SHAPEIT4</italic>-phased positions for each chromosome. In addition, a separate VCF file is created that only includes phased positions of the child where one of the nucleotides was not identified in either parent. These phased positions may be the result of genotype errors or de novo variants. This file is meant to be informative and allow the user to determine how these positions should be used in downstream analyses.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>trioPhaser results for 52 trios</title>
      <p id="Par16">Whole-genome sequencing (WGS) data for an Ashkenazim trio and a Han Chinese trio were used to test trioPhaser. Data for these trios were generated by the Genome in a Bottle (GIAB) Consortium [<xref ref-type="bibr" rid="CR16">16</xref>]. We used GRCh38-aligned BAM files (available through GIAB FTP server) as input into <italic>GATK</italic>’s “HaplotypeCaller” tool to generate gVCF files for each member of each trio. The gVCF files for each trio were then used as input into trioPhaser.</p>
      <p id="Par17">In addition to validating trioPhaser with GIAB data, we ran trioPhaser on 50 trios where the child in each trio had been diagnosed with neuroblastoma. These trios and their associated gVCF files are available through the Gabriella Miller Kids First Data Resource Center [<xref ref-type="bibr" rid="CR17">17</xref>]. The gVCF files were generated using WGS data.</p>
      <p id="Par18">For the GIAB and 50 neuroblastoma trios, trioPhaser produced a greater number of phased positions than would be provided by using either Mendelian inheritance logic or <italic>SHAPEIT4</italic>, exclusively (Table <xref rid="Tab1" ref-type="table">1</xref>). Mendelian inheritance logic can be used to phase a greater number of positions than <italic>SHAPEIT4</italic> because Mendelian inheritance logic can be applied to multi-allelic positions and does not rely on a haplotype reference panel. However, <italic>SHAPEIT4</italic> provides the added benefit of being able to phase positions where all individuals in a trio are heterozygous for the same nucleotides (given that the positions are bi-allelic and are found within the haplotype reference panel). Overall run-time varies for any given trio based on the number of CPUs available, total number of genotyped variants, and variant Phred-scaled quality threshold. For example, average run-time across the 50 neuroblastoma trios was less than the GIAB trios because at a Phred-scaled quality threshold of 30, there were fewer variants available for phasing than the GIAB trios.<table-wrap id="Tab1"><label>Table 1</label><caption><p>trioPhaser results for an Ashkenazim trio, Han Chinese trio, and 50 neuroblastoma trios</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Ashkenazim trio</th><th align="left">Han Chinese trio</th><th align="left">50 neuroblastoma trios</th></tr></thead><tbody><tr><td align="left">Genotyped variants</td><td align="left">5,477,879</td><td align="left">5,040,806</td><td align="left"><p>5,976,380</p><p>sd: 321,208</p></td></tr><tr><td align="left">Variants phased by trioPhaser</td><td align="left">4,640,241 (84.7%)</td><td align="left">4,490,039 (89.1%)</td><td align="left"><p>4,469,479 (75.0%)</p><p>sd: 171,916</p></td></tr><tr><td align="left">Variants phased exclusively using Mendelian inheritance logic</td><td align="left">867,181 (18.7%)</td><td align="left">767,992 (17.1%)</td><td align="left"><p>721,415 (16.1%)</p><p>sd: 54,522</p></td></tr><tr><td align="left">Variants phased exclusively by SHAPEIT4</td><td align="left">458,361 (9.9%)</td><td align="left">417,138 (9.3%)</td><td align="left"><p>420,793 (9.4%)</p><p>sd: 15,414</p></td></tr><tr><td align="left">Run-time (22 CPUs used)</td><td align="left">5.8 h</td><td align="left">5.4 h</td><td align="left">4.4 h</td></tr></tbody></table><table-wrap-foot><p>trioPhaser uses Mendelian inheritance in conjunction with <italic>SHAPEIT4</italic>. This hybrid approach produced a greater number of phased positions than was provided using either method exclusively. Results for the 50 neuroblastoma trios were averaged</p><p>sd = Standard deviation</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8">
      <title>Comparison of trioPhaser to linked-read phasing technology</title>
      <p id="Par19">In addition to BAM files, GIAB provides phased VCF files for each member of the Ashkenazim trio and Han Chinese trio. These data had been phased using linked-read technology (10X Genomics) which is a laboratory-based phasing method that randomly partitions small amounts of DNA to decrease the chance of a single partition having DNA from the same genomic position [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. This laboratory-based phasing method has been shown to be one of the most accurate [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, we used these trios as our “gold standard” to evaluate how similar the phased results of trioPhaser were to the linked-read technology results.</p>
      <p id="Par20">trioPhaser produced similar phased calls as linked-read phasing technology and is a suitable alternative for phasing trios. For the Ashkenazim trio, trioPhaser and 10X Genomics had 3,999,945 variants that were congruent (those that had the same position, reference allele, and alternate allele). Of the congruent variants, 3,952,525 (98.8%) were phased identically. For the Han Chinese trio, 4,000,682 variants were congruent between the 10X-phased and trioPhaser-phased data; of these variants, 3,900,447 (97.5%) were phased identically.</p>
    </sec>
    <sec id="Sec9">
      <title>Comparison of trioPhaser to WhatsHap</title>
      <p id="Par21"><italic>WhatsHap</italic> is a read-based phasing method that uses sequencing reads to reconstruct haplotypes [<xref ref-type="bibr" rid="CR6">6</xref>]. This phasing method requires BAM file(s) and a VCF file as inputs. Incorporating sequencing reads as part of the phasing process can increase the overall accuracy of phase results [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, we phased the Ashkenazim and Han Chinese trios using <italic>WhatsHap</italic> to compare the phasing output of read-backed phasing to trioPhaser. Before phasing with <italic>WhatsHap</italic>, we used <italic>GATK</italic>’s “CombineGVCFs” tool to combine the gVCF files we previously created for the Ashkenazim trio and Han Chinese trio, and then joint-genotyped each combined trio using <italic>GATK</italic>’s “GenotypeGVCFs” tool. This joint-genotyped file for each trio and the GRCh38-aligned BAM files for each member of each trio were used as input into <italic>WhatsHap</italic>. The phased VCF output by <italic>WhatsHap</italic> only includes heterozygous positions. Therefore, we only compared heterozygous positions between trioPhaser and <italic>WhatsHap</italic>.</p>
      <p id="Par22">trioPhaser produced similar phased calls on heterozygous positions as <italic>WhatsHap</italic> and is a suitable phasing alternative. For the Ashkenazim trio, trioPhaser and <italic>WhatsHap</italic> had 2,275,546 phased heterozygous variants that were congruent. Of the congruent variants, 2,204,240 (96.9%) were phased identically. 1,959,580 (88.9%) of the congruent positions could be phased using Mendelian inheritance logic and 100% percent of these positions were phased identically between trioPhaser and <italic>WhatsHap</italic>. <italic>WhatsHap</italic> took 26.6 h to phase compared to trioPhaser, which took 5.8 h. For the Han Chinese trio, 2,070,536 phased heterozygous variants were congruent between trioPhaser and <italic>WhatsHap</italic> and of these variants, 1,997,276 (96.5%) were phased identically. 1,777,588 (89.0%) of the congruent positions could be phased using Mendelian inheritance logic, and 100% percent of these positions were phased identically between trioPhaser and <italic>WhatsHap</italic>. <italic>WhatsHap</italic> took 26.6 h to phase compared to trioPhaser, which took 5.4 h.</p>
      <p id="Par23">The source code and a detailed document explaining where data was downloaded from, how it was processed, and how to run trioPhaser is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/dmiller903/trioPhaser/blob/main/validate/validate.pdf">https://github.com/dmiller903/trioPhaser</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Conclusion</title>
    <p id="Par24">trioPhaser is a containerized phasing tool that implements Mendelian inheritance logic and <italic>SHAPEIT4</italic> to phase trios. Using both phasing methods produces a greater overall number of phased variants than would be output when using either method alone. In fact, on average, trioPhaser increased the total number of phased variants by 21.0% and 10.5%, respectively, when compared to what <italic>SHAPEIT4</italic> or Mendelian inheritance logic were able to phase alone. We show that, on average, 98.2% of the congruent 10X-phased haplotype calls, and 96.7% of the congruent <italic>WhatsHap</italic> haplotype calls are the same as trioPhaser. trioPhaser is a suitable phasing alternative for trios when gVCF files are available or can be generated.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>GIAB</term>
        <def>
          <p id="Par4">Genome in a bottle</p>
        </def>
      </def-item>
      <def-item>
        <term>WGS</term>
        <def>
          <p id="Par5">Whole-genome sequencing</p>
        </def>
      </def-item>
      <def-item>
        <term>sd</term>
        <def>
          <p id="Par6">Standard deviation</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>The results analyzed and published here are based in part upon data generated by Gabriella Miller Kids First Pediatric Research Program projects phs001436.v1.p1, and were accessed from the Kids First Data Resource Portal (<ext-link ext-link-type="uri" xlink:href="https://kidsfirstdrc.org">https://kidsfirstdrc.org</ext-link>) and/or dbGaP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gap">www.ncbi.nlm.nih.gov/gap</ext-link>).</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>DBM developed trioPhaser, wrote and tested the code, and prepared the manuscript. SRP provided insight and edited the manuscript. Both authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Not applicable.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The Genome in a Bottle data underlying this article are available at <ext-link ext-link-type="uri" xlink:href="ftp://ftp-trace.ncbi.nlm.nih.gov/ReferenceSamples/giab/data/AshkenazimTrio/analysis/10XGenomics_ChromiumGenome_LongRanger2.0_06202016/">ftp://ftp-trace.ncbi.nlm.nih.gov/ReferenceSamples/giab/data/AshkenazimTrio/analysis/10XGenomics_ChromiumGenome_LongRanger2.0_06202016/</ext-link>. The Gabriella Miller Kids First data underlying this article cannot be shared publicly due to access restrictions. However, access for these data can be requested through dbGap at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001436.v1.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001436.v1.p1</ext-link>.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability and requirements</title>
    <p>Project name: <italic>trioPhaser</italic>.</p>
    <p>Project home page: <ext-link ext-link-type="uri" xlink:href="https://github.com/dmiller903/trioPhaser">https://github.com/dmiller903/trioPhaser</ext-link>.</p>
    <p>Project source code: <ext-link ext-link-type="uri" xlink:href="https://github.com/dmiller903/trioPhaser">https://github.com/dmiller903/trioPhaser</ext-link>.</p>
    <p>Operating system: Linux, Windows, or MacOS.</p>
    <p>Programming language: Python3.</p>
    <p>Other requirements: <italic>trioPhaser</italic> requires that the Docker engine be installed.</p>
    <p>License: MIT.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par25">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par26">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par27">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Kirkness</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Telenti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schork</surname>
            <given-names>NJ</given-names>
          </name>
        </person-group>
        <article-title>Comparison of phasing strategies for whole human genomes</article-title>
        <source>PLoS Genet</source>
        <year>2018</year>
        <volume>14</volume>
        <fpage>e1007308</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1007308</pub-id>
        <pub-id pub-id-type="pmid">29621242</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Snyder</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Adey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kitzman</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Shendure</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Haplotype-resolved genome sequencing: experimental methods and applications</article-title>
        <source>Nat Rev Genet</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>344</fpage>
        <lpage>358</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3903</pub-id>
        <pub-id pub-id-type="pmid">25948246</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Piccolo</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Compound heterozygous variants in pediatric cancers: a systematic review</article-title>
        <source>Front Genet</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>493</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2020.00493</pub-id>
        <pub-id pub-id-type="pmid">32508881</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Piccolo</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>a survey of compound heterozygous variants in pediatric cancers and structural birth defects</article-title>
        <source>Front Genet</source>
        <year>2021</year>
        <volume>12</volume>
        <fpage>363</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2021.640242</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Delaneau</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zagury</surname>
            <given-names>J-F</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Dermitzakis</surname>
            <given-names>ET</given-names>
          </name>
        </person-group>
        <article-title>Accurate, scalable and integrative haplotype estimation</article-title>
        <source>Nat Commun</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>5436</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-019-13225-y</pub-id>
        <pub-id pub-id-type="pmid">31780650</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <mixed-citation publication-type="other">Martin M, Patterson M, Garg S, Fischer SO, Pisanti N, Klau GW, Schöenhuth A, Marschall T. WhatsHap: fast and accurate read-based phasing 2016. bioRxiv:085050.</mixed-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garg</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Computational methods for chromosome-scale haplotype reconstruction</article-title>
        <source>Genome Biol</source>
        <year>2021</year>
        <volume>22</volume>
        <fpage>101</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-021-02328-9</pub-id>
        <pub-id pub-id-type="pmid">33845884</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roach</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Glusman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hubley</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Montsaroff</surname>
            <given-names>SZ</given-names>
          </name>
          <name>
            <surname>Holloway</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Mauldin</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Srivastava</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Garg</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Pollard</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Galas</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Hood</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Smit</surname>
            <given-names>AFA</given-names>
          </name>
        </person-group>
        <article-title>Chromosomal haplotypes by genetic phasing of human families</article-title>
        <source>Am J Hum Genet</source>
        <year>2011</year>
        <volume>89</volume>
        <fpage>382</fpage>
        <lpage>397</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.07.023</pub-id>
        <pub-id pub-id-type="pmid">21855840</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Delaneau</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Howie</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Zagury</surname>
            <given-names>J-F</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Haplotype estimation using sequencing reads</article-title>
        <source>Am J Hum Genet</source>
        <year>2013</year>
        <volume>93</volume>
        <fpage>687</fpage>
        <lpage>696</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.09.002</pub-id>
        <pub-id pub-id-type="pmid">24094745</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Greenfield</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wittorff</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Hultner</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The importance of data compression in the field of genomics</article-title>
        <source>IEEE Pulse</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>20</fpage>
        <lpage>23</lpage>
        <pub-id pub-id-type="doi">10.1109/MPULS.2019.2899747</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Piccolo</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>CompoundHetVIP: compound heterozygous variant identification pipeline</article-title>
        <source>F1000Res</source>
        <year>2020</year>
        <volume>9</volume>
        <fpage>1211</fpage>
        <pub-id pub-id-type="doi">10.12688/f1000research.26848.1</pub-id>
        <pub-id pub-id-type="pmid">33680433</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boettiger</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>An introduction to Docker for reproducible research</article-title>
        <source>Oper Syst Rev</source>
        <year>2015</year>
        <volume>49</volume>
        <fpage>71</fpage>
        <lpage>79</lpage>
        <pub-id pub-id-type="doi">10.1145/2723872.2723882</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">GATK|Tool Documentation Index. <ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/gatk/documentation/tooldocs/3.8-0/org_broadinstitute_gatk_tools_walkers_phasing_ReadBackedPhasing.php">https://software.broadinstitute.org/gatk/documentation/tooldocs/3.8-0/org_broadinstitute_gatk_tools_walkers_phasing_ReadBackedPhasing.php</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25:2078–2079.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <mixed-citation publication-type="other">1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR. A global reference for human genetic variation. Nature 2015; 526:68–74.</mixed-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zook</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>McDaniel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Olson</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Parikh</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Heaton</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Irvine</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Trigg</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Truty</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McLean</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>De La Vega</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sherry</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Salit</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>An open resource for accurately benchmarking small variant and reference calls</article-title>
        <source>Nat Biotechnol</source>
        <year>2019</year>
        <volume>37</volume>
        <fpage>561</fpage>
        <lpage>566</lpage>
        <pub-id pub-id-type="doi">10.1038/s41587-019-0074-6</pub-id>
        <pub-id pub-id-type="pmid">30936564</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Heath</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Raman</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lilly</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Storm</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Waanders</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Ferretti</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Yung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mattioni</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Davis-Dusenbery</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Flamig</surname>
            <given-names>ZL</given-names>
          </name>
          <name>
            <surname>Grossman</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Volchenboum</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Mueller</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nazarian</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vasilevsky</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Haendel</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Resnick</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Abstract 2464: Gabriella Miller kids first data resource center: harmonizing clinical and genomic data to support childhood cancer and structural birth defect research</article-title>
        <source>Cancer Res</source>
        <year>2019</year>
        <volume>79</volume>
        <fpage>2464</fpage>
        <lpage>2464</lpage>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>GXY</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>BT</given-names>
          </name>
          <name>
            <surname>Schnall-Levin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jarosz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Hindson</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Kyriazopoulou-Panagiotopoulou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Masquelier</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Merrill</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Terry</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Mudivarti</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Wyatt</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Bharadwaj</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Makarewicz</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Belgrader</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Lowe</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Marks</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Vurens</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Hardenbol</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Montesclaros</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Greenfield</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Birch</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Short</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Bjornson</surname>
            <given-names>KP</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hopmans</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Wood</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lockwood</surname>
            <given-names>GK</given-names>
          </name>
          <name>
            <surname>Stafford</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Delaney</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ordonez</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Grimes</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Greer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Belhocine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Giorda</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Heaton</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>McDermott</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Bent</surname>
            <given-names>ZW</given-names>
          </name>
          <name>
            <surname>Meschi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kondov</surname>
            <given-names>NO</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bernate</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Gauby</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kindwall</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bermejo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fehr</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Saxonov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ness</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Hindson</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>HP</given-names>
          </name>
        </person-group>
        <article-title>Haplotyping germline and cancer genomes with high-throughput linked-read sequencing</article-title>
        <source>Nat Biotechnol</source>
        <year>2016</year>
        <volume>34</volume>
        <fpage>303</fpage>
        <lpage>311</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.3432</pub-id>
        <pub-id pub-id-type="pmid">26829319</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
